Qualisure News

Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

2022 American Thyroid Association – Dr. Oliver Bathe

Molecular subgroups identified by machine learning enable accurate prognostication of papillary thyroid cancer [2021]

Dr. Cynthia Stretch (CSO) gave a podium presentation at the Annual Meeting of the Canadian Association of Surgical Oncologists

Qualisure researcher receives award for presentation at the World Congress of Surgery

Abstract: RAI GuidePx: A robust predictor for radioactive iodine sensitivity status in papillary thyroid cancer leveraging thyroid differentiation genes.

Abstract: Molecular subtypes in radiation induced papillary thyroid cancer using Thyroid GuidePx.

The Technological Drivers Powering Precision Oncology

Unique Thyroid Cancer Tests: New Hope Unveiled

Understanding Radioactive Iodine Resistance in Thyroid Cancer: Overcoming Treatment Challenges

Radioactive Iodine Therapy: A Precision Weapon against Thyroid Cancer

Subscribe For Updates on Testing & Diagnostics

Sign up to receive updates from Qualisure regarding our latest developments in precision medicine tools.

First Name

Last Name

Email Address

Telephone

Organization

Country

I am a(n)

consent_sub

I consent to the use of my personal information for the purpose of receiving updates and communications about the latest developments in Precision Oncology.

Get Started

Thyroid GuidePx®

News

Investors